MAL antibody
Principal name
MAL antibody
Alternative names for MAL antibody
Myelin and lymphocyte protein, T-lymphocyte maturation-associated protein
Ncbi ID
9606, NP_002362.1, NM_022438, NM_022440, NP_002362, NP_071885, NP_071883, NP_001164658.1, NM_001171187, NM_012798, NM_002371, NM_022439
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), ELISA (detection) (E(detection)), Western blot / Immunoblot (WB)
Background of MAL antibody
- Kit Component:
- - KN309682G1, Mal gRNA vector 1 in pCas-Guide vector
- KN309682G2, Mal gRNA vector 2 in pCas-Guide vector
- KN309682D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP301256 | MAL (transcript variant a) |
||||
| Recombinant protein of human mal, T-cell differentiation protein (MAL), transcript variant a | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
| TP311612 | MAL (transcript variant d) |
||||
| Recombinant protein of human mal, T-cell differentiation protein (MAL), transcript variant d | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
| TP317248 | MAL (transcript variant b) |
||||
| Recombinant protein of human mal, T-cell differentiation protein (MAL), transcript variant b | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY411702 | MAL overexpression lysate |
|
 |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. | ||
| LY411704 | MAL overexpression lysate |
|
|
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. | ||
| LY429682 | MAL overexpression lysate |
|
|
0.1 mg /
€315.00
|
|
| OriGene Technologies, Inc. | ||
| LY429684 | MAL overexpression lysate |
|
|
0.1 mg /
€315.00
|
|
| OriGene Technologies, Inc. |
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR219326L2V | Lenti ORF particles, Mal (GFP-tagged) - Mouse myelin and lymphocyte protein, T-cell differentiation protein (Mal), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| MR219326L1V | Lenti ORF particles, Mal (Myc-DDK-tagged) - Mouse myelin and lymphocyte protein, T-cell differentiation protein (Mal), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||
Rat Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RR215532L2V | Lenti ORF particles, Mal (GFP-tagged ORF) - Rat mal, T-cell differentiation protein (Mal), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||